Follow Us TR

News Details

U.S. Government Exercises Option To Purchase Additional RAPIVAB® from BioCryst for Delivery to Strategic National Stockpile

About BioCryst Pharmaceuticals, Inc.
  • NASDAQ: $BCRX
  • Notified: $4.01
  • 07:01 EDT

Price Chart